159 related articles for article (PubMed ID: 26845881)
1. [Electrophysiological evaluation of retinal function after systemic and superselective intra-arterial chemotherapy for retinoblastoma].
Zueva MV; Saakyan SV; Zueva MV; Saakyan SV
Vestn Oftalmol; 2015; 131(5):111-114. PubMed ID: 26845881
[TBL] [Abstract][Full Text] [Related]
2. ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma.
Brodie SE; Paulus YM; Patel M; Gobin YP; Dunkel IJ; Marr BP; Abramson DH
Br J Ophthalmol; 2012 Jun; 96(6):877-80. PubMed ID: 22426950
[TBL] [Abstract][Full Text] [Related]
3. [Evoked retinal and cortical potentials in children with advanced and resistant retinoblastoma after neoadjuvant polychemotherapy and superselective intra-arterial chemotherapy].
Zueva MV; Tsapenko IV; Saakian SV; Panteleeva OG; Zharua AA; Orlovskaia LS
Vestn Oftalmol; 2014; 130(5):22-9. PubMed ID: 25711058
[TBL] [Abstract][Full Text] [Related]
4. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
5. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Arch Ophthalmol; 2010 Mar; 128(3):370-2. PubMed ID: 20212212
[No Abstract] [Full Text] [Related]
6. Non-selectivity of ERG reductions in eyes treated for retinoblastoma.
Liu CY; Jonna G; Francis JH; Marr BP; Abramson DH; Brodie SE
Doc Ophthalmol; 2014 Feb; 128(1):13-23. PubMed ID: 24213436
[TBL] [Abstract][Full Text] [Related]
7. Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function.
Abdelhakim AH; Francis JH; Marr BP; Gobin YP; Abramson DH; Brodie SE
Br J Ophthalmol; 2017 May; 101(5):623-628. PubMed ID: 27539090
[TBL] [Abstract][Full Text] [Related]
8. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
9. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
[TBL] [Abstract][Full Text] [Related]
10. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
11. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
13. Chemosurgery for retinoblastoma: what we know after 5 years.
Abramson DH
Arch Ophthalmol; 2011 Nov; 129(11):1492-4. PubMed ID: 22084221
[No Abstract] [Full Text] [Related]
14. Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma.
Mohney BG; Elner VM; Smith AB; Harbour JW; Smith BD; Musch DC; Smith SJ
Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):151-159. PubMed ID: 28195618
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial chemotherapy in retinoblastoma - A paradigm change.
Manjandavida FP; Stathopoulos C; Zhang J; Honavar SG; Shields CL
Indian J Ophthalmol; 2019 Jun; 67(6):740-754. PubMed ID: 31124482
[TBL] [Abstract][Full Text] [Related]
16. Complete regression of retinoblastoma following intra-arterial chemotherapy.
Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
[TBL] [Abstract][Full Text] [Related]
17. Retinal vascular precipitates during administration of melphalan into the ophthalmic artery.
Superstein R; Lederer D; Dubois J; Hamel P; Carret AS; Callejo S
JAMA Ophthalmol; 2013 Jul; 131(7):963-5. PubMed ID: 23846208
[No Abstract] [Full Text] [Related]
18. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey.
Shields CL; Shields JA
Clin Exp Ophthalmol; 2010 Aug; 38(6):638-43. PubMed ID: 20584015
[TBL] [Abstract][Full Text] [Related]
19. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
Padrón-Pérez N; Català-Mora J
J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
[No Abstract] [Full Text] [Related]
20. Retinoblastoma: evidence for stage-based chemotherapy.
Chung CY; Medina CA; Aziz HA; Singh AD
Int Ophthalmol Clin; 2015; 55(1):63-75. PubMed ID: 25436494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
